Carl-Gustav Pihl

Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial.

A. Vickers, J. Hugosson, H. Lilja, 2022, European urology.

Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate‐specific antigen

P. Scardino, A. Vickers, J. Hugosson, 2010, Cancer.

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

Andrew J Vickers, Kim Pettersson, Angel M Cronin, 2008, BMC medicine.

The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable.

J. Hugosson, H. Lilja, G. Aus, 2004, The Journal of urology.

Results of a randomized, population‐based study of biennial screening using serum prostate‐specific antigen measurement to detect prostate carcinoma

Hans Lilja, J. Hugosson, H. Lilja, 2004, Cancer.

Population‐based screening for prostate cancer by measuring free and total serum prostate‐specific antigen in Sweden

J. Hugosson, H. Lilja, P. Fernlund, 2003, BJU international.